Valuation check: HOVNP's P/E ratio is 125.15, above the Healthcare sector average of 26.85.
Get informed when a big investor buys or sells
+ Follow125.15
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for HOVNP is 125.15. That is above the Healthcare sector average of 26.85. Investors often review this figure alongside Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, HOVNP currently prints 125.15 for P/E ratio, while the sector average sits near 26.85. That is roughly 366.2% above the sector mean. Large gaps often invite a closer look at Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's growth, margins, and balance sheet.
A P/E ratio of 125.15 for Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A is not 'good' or 'bad' on its own. Compare it with the peer average (26.85) and with HOVNP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting HOVNP's P/E ratio (125.15), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.